Cellular immune response in rats with 1,2-dimethylhydrazine-induced colon cancer after transplantation of placenta-derived multipotent cells
Authors:
Open Access
- 31 May 2016
- journal article
- Published by Institute of Cell Therapy in Cell and Organ Transplantology
- Vol. 4 (1) , 55-60
Abstract
We describe the state of the immune system at the late stage of 1,2-dimethylhydrazine (DMH)-induced colon cancer and after administration of placenta-derived multipotent cells (PDMCs). The spleen and thymus indices did not differ among the groups of intact and DMH-treated rats and were not affected by the administration of placenta-derived multipotent cells following the DMH treatment. Moreover, no difference in spontaneous or stimulated phagocytic activity of peritoneal macrophages was observed between healthy rats or the animals with DMH-induced colon cancer (with or without the administration of PDMCs). However, the proliferation of the T cells in the spleen was lower in rats with colon cancer regardless of the administration of PDMCs. Similarly, no changes were observed in the cell cycle distribution of proliferating spleen cells after stimulation by lipopolysaccharide.Conclusion. Our data demonstrate the absence of the active reaction by peritoneal macrophages and spleen cells to a colon cancer at mid/late stage. Additionally, the administration of PDMCs does not result in a measurable anti-tumor immune response.Keywords
This publication has 25 references indexed in Scilit:
- Profiles of circulating inflammatory cytokines in colorectal cancer (CRC), high cancer risk conditions, and health are distinct. Possible implications for CRC screening and surveillanceCancer Letters, 2013
- Prognostic value of circulating cytokines for stage III colon cancerJournal of Surgical Research, 2013
- Macrophages promote tumour growth and liver metastasis in an orthotopic syngeneic mouse model of colon cancerInternational Journal of Colorectal Disease, 2013
- Placenta-derived stem cells: new hope for cell therapy?Cytotechnology, 2008
- Tumor infiltrating macrophages reduce development of peritoneal colorectal carcinoma metastasesCancer Letters, 2008
- Activation of human peritoneal immune cells in early stages of gastric and colon cancerSurgery, 2007
- Normal Structure, Function, and Histology of the SpleenToxicologic Pathology, 2006
- Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: Results of a population-based studyInflammatory Bowel Diseases, 2006
- Structure and function of the spleenNature Reviews Immunology, 2005
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002